Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro
Background: Aspirin(acetylsalicylic acid, ASA) is recommended for the secondary prevention of atherothrombotic events and has shown anticancer effects. The current enteric-coated drug formulation may reduce aspirin bioavailability. Liquid formulations could improve aspirin pharmacokinetics and pharm...
Saved in:
Main Authors: | Ulrika Hofling (Author), Stefania Tacconelli (Author), Annalisa Contursi (Author), Annalisa Bruno (Author), Matteo Mucci (Author), Patrizia Ballerini (Author), Simon Cohen (Author), Paola Patrignani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
by: Patrizia Ballerini, et al.
Published: (2022) -
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action
by: Paola Patrignani, et al.
Published: (2024) -
The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing
by: Paola Patrignani, et al.
Published: (2024) -
P2Y12 Receptors in Tumorigenesis and Metastasis
by: Patrizia Ballerini, et al.
Published: (2018) -
A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
by: Alessandra Ammazzalorso, et al.
Published: (2024)